When I decided to travel to Mexico in the middle of the pandemic for more than a month, I didn’t have many supporters among my friends and family, with fair concern. The country is currently one of the hardest hit by the virus — and is now approaching nearly 900,000 cases. Traveling now clearly isn’t…
Times Insider explains who we are and what we do, and delivers behind-the-scenes insights into how our journalism comes together. In September, Marilyn Monroe received a New York Times byline. The story? The star’s recipe for stuffing. Monroe was one of thousands of recipe creators who recently received authorship credit for dishes that have been…
Years ago, I took to the stage with the Royal Melbourne Philharmonic Choir. We sang Handel’s Messiah, Fauré’s Requiem and the Dream of Gerontius in the Town Hall. There I was, my feet in sensible shoes, sweat staining my crisp white shirt, singing my little heart out in front of the giant organ. I still…
Despite significant investment in health information technology such as computerized health records and clinical decision support, leveraging the technology to improve the quality of care will require significant and sustained effort by health systems, according to a new RAND Corporation study. In order to accelerate change, better mechanisms for creating and disseminating best practices are…
In the world of rare genetic diseases, exome and genome sequencing are two powerful tools used to make a diagnosis. A recent addition to the toolkit, RNA sequencing, has been demonstrated to help researchers narrow down disease candidate variants identified first on exome and genome sequencing. A new study from Baylor College of Medicine finds…
Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population. Researchers from Baylor College of Medicine and the University of Pittsburgh…
Rye Brook, NY (Monday, October 26, 2020) – Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal. The Beat AML…
The body’s immune system defeats diseases by sensing foreign invaders, like bacteria or viruses, and then mounting a response against them. But just how immune cell receptors work together to sense multiple molecules and make these decisions remained a mystery. Now, researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago…
KNOXVILLE, Tenn. – How much will it cost? For many, this question is the most critical determining factor in receiving quality medical care but can be difficult to broach with a health care provider. A new research effort led by the University of Tennessee Institute of Agriculture aims to better facilitate these conversations, leading to…
LA JOLLA, CA–Scientists at Scripps Research have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting in blindness. Many serious eye diseases–including age-related macular degeneration, diabetic retinopathy and related disorders of the retina–feature abnormal overgrowth of new retinal blood vessel branches, which can lead to…